ADMA Biologics, Inc. (ADMA) NASDAQ
15.15
+0.16(+1.07%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.15
+0.16(+1.07%)
Currency In USD
| Market Cap | 4.35B |
| Enterprise Value | 4.34B |
| P/E Ratio | 24.54 |
| PEG Ratio | -0.82 |
| Price/Sales Ratio | 7.07 |
| Price/Book Ratio | 7.55 |
| Enterprise/Revenue | 7.06 |
| Enterprise/EBITDA | 18.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.29 |
| Operating Margin | 0.38 |
| Return On Assets | 0.24 |
| Return On Equity | 0.35 |
| Revenue | 510.17M |
| Revenue/Share | 2.14 |
| Gross Profit | 292.77M |
| EBITDA | 197.86M |
| Net Income | 146.93M |
| Diluted EPS | 0.6 |
| Total Cash | 87.63M |
| Total Cash/Share | 0.37 |
| Total Debt | 79.89M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 6.71 |
| Book Value Per Share | 2.01 |
| 52-Week Change | -17.8 |
| 52-Week High | 25.67 |
| 52-Week Low | 13.76 |
| Moving Average 50 Days | 16.75 |
| Moving Average 200 Days | 17.23 |
| Average Volume | 2.62M |
| Shares Outstanding | 238.16M |
| % Held by Institutions | 92.23 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |